What is Reviva Pharmaceuticals Holdings Inc. Annual Net Profit?

Reviva Pharmaceuticals Holdings Inc. Annual Net Profit rose 23.79% in the last year to $29.92 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Reviva Pharmaceuticals Holdings Inc. Price to Earning Ratio?

Reviva Pharmaceuticals Holdings Inc. Price to Earning Ratio is -1.33, which is negative.

What is Reviva Pharmaceuticals Holdings Inc. Stock Price?

Reviva Pharmaceuticals Holdings Inc. Stock Price fell 41.43% and underperformed its sector by 67.43% in the past year.

What is Reviva Pharmaceuticals Holdings Inc. Quarterly Net profit?

Reviva Pharmaceuticals Holdings Inc. Quarterly Net profit rose 13.46% YoY to $6.43 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Reviva Pharmaceuticals Holdings Inc. Debt to Equity Ratio?

Reviva Pharmaceuticals Holdings Inc. Debt to Equity Ratio of 0.56 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Reviva Pharmaceuticals Holdings Inc. Return on Equity(ROE)?

Reviva Pharmaceuticals Holdings Inc. Return on Equity(ROE) for the last financial year was -916.17%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Reviva Pharmaceuticals Holdings Inc. Mutual Fund Holding?

Reviva Pharmaceuticals Holdings Inc. Mutual Fund Holding increased by 0.6% in the last quarter to 8.05.

What is Reviva Pharmaceuticals Holdings Inc. Interest Coverage Ratio?

Reviva Pharmaceuticals Holdings Inc. Interest Coverage Ratio is -1615.44, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Reviva Pharmaceuticals Holdings Inc. Institutional Holding?

Reviva Pharmaceuticals Holdings Inc. Institutional Holding increased by 0.77% in the last quarter to 17.87.

Reviva Pharmaceuticals Holdings Inc. XNAS: RVPH

Reviva Pharmaceuticals Holdings Inc. Live Share Price Today, Share Analysis and Chart

Name: Reviva Pharmaceuticals Holdings Inc.: Is Infosys Ltd. worth buying?
Item: Reviva Pharmaceuticals Holdings Inc.
Rating: 0.88650
Author: Trendlyne DVM scores

about

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and ca...

0.82 0.00 (0.00%)

80.84% Fall from 52W High

181.9K XNAS Volume

XNAS 05 Jun, 2025 11:32 AM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Neutral

35.5 / 100

No estimates available

Reviva Pharmaceuticals Hol... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Reviva Pharmaceuticals Holdings Inc. FAQ

How is Reviva Pharmaceuticals Holdings Inc. today?

Reviva Pharmaceuticals Holdings Inc. today is trading in the red, and is down by 0.00% at 0.82.

How has Reviva Pharmaceuticals Holdings Inc. performed historically?

Reviva Pharmaceuticals Holdings Inc. is currently trading down 0.00% on an intraday basis. In the past week the stock fell -26.79%. stock has been down -34.40% in the past quarter and fell -41.43% in the past year. You can view this in the overview section.